Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-16

FDA Approved: PIMAVANSERIN — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approved the original Abbreviated New Drug Application for Pimavanserin (Pimavanserin) by Novadoz Pharmaceuticals LLC, authorizing a generic version for mar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pimavanserin (pimavanserin)

Snippet

ORIG AP for PIMAVANSERIN (PIMAVANSERIN)